IP Library Granted Patent US 7,790,702
Granted Patent B2
US 7,790,702 · App. 11/368,645 · Granted Sep 7, 2010

Lipid metabolism improving agent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,702
App. No.
11/368,645
Granted
Sep 7, 2010
Kind
B2
Abstract

The present invention relates to a protein/phospholipid or protein hydrolyzate/phospholipid complex containing 10 wt % or more of bound phospholipid, a lipid metabolism improving agent comprising the complex, and a functional food comprising the complex. The present invention provides a lipid metabolism improving agent and a functional food, containing the complex.

Claims (9)

1. A method for lowering serum cholesterol of an animal, which comprises administering to the animal a protein hydrolyzate/phospholipid complex, said complex containing at least 10 wt % of bound phospholipid, said bound phospholipid in the complex being a phospholipid which remains bound to the protein hydrolyzate after being treated with a nonpolar organic solvent, wherein said protein is soybean protein and said phospholipid is phospholipase A2-modified phospholipid.

2. A method for producing food or feed, which comprises adding, to a food or feed material, a protein hydrolyzate/phospholipid complex, said protein hydrolyzate/phospholipid complex containing at least 10 wt % of bound phospholipid, said bound phospholipid in the complex being a phospholipid which remains bound to the protein hydrolyzate after being treated with a nonpolar organic solvent, wherein said protein is soybean protein and said phospholipid is phospholipase A2-modified phospholipid.

3. The method according to claim 1 , wherein the phospholipase A2-modified phospholipid is phospholipase A2-modified lecithin obtainable by treating lecithin with phospholipase A2.

4. The method according to claim 1 , wherein the animal is human.

5. The method according to claim 2 , wherein the phospholipase A2-modified phospholipid is phospholipase A2-modified lecithin obtainable by treating lecithin with phospholipase A2.

6. The method according to claim 1 , wherein said complex contains 10-50 wt % of the bound phospholipid.

7. The method according to claim 6 , wherein said complex contains 20-50 wt % of the bound phospholipid.

8. The method according to claim 2 , wherein said complex contains 10-50 wt % of the bound phospholipid.

9. The method according to claim 8 , wherein said complex contains 20-50 wt % of the bound phospholipid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2009
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO BIO CO., LTD.
Reel/Frame 022787/0667 →